[Management of subclinical hyperthyroidism].
Management of subclinical hyperthyroidism (low TSH and normal thyroid hormones) is controversial. Knowledge of its causes, clinical context and associated morbidity is required. It is recommended to follow six steps in exploration and treatment: 1) confirmation, 2) estimation of severity, 3) cause assessment, 4) study of complications, 5) balance whether treatment is needed and 6) if necessary, choice of the most appropriate form. In its management, the same treatments are used as in overt hyperthyroidism.
Galofré
Juan Carlos
JC
Departamento de Endocrinologia y Nutrición, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, España. jcgalofre@unav.es
D000236:Adenoma / Q000150:complications; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000465:Algorithms; D019468:Disease Management; D006044:Goiter, Nodular / Q000150:complications; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008875:Middle Aged; D013963:Thyroid Hormones / Q000097:blood; D013964:Thyroid Neoplasms / Q000150:complications; D013965:Thyroidectomy / Q000379:methods; D013966:Thyroiditis / Q000150:complications; D013972:Thyrotropin / Q000097:blood / Q000172:deficiency
D000319:Adrenergic beta-Antagonists; D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D013972:Thyrotropin